TENON MEDICAL INC (TNON)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$3.72-1.33%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · TNON
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(24.2) + peer(0.2*23.4) + term(0.0) → 13.16% (capped ±15.0)
Calibrated likelihood the company misses analyst consensus on its next print, read from its own miss history plus its industry base rate. A fundamental tilt, not a price call — and a quiet watch-flag, not an alarm.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and is on a run of consecutive earnings misses. A fundamental tilt, not a price call.
Calibrated. Base rate ~24%.
Consecutive quarters it missed, most recent run.
How often this industry misses, baseline.
Industry peers that missed in the recent window.
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition. On August 13, 2026, Tenon Medical, Inc., a Delaware corporation (the “Company”), issued a press release (the “Press Release”) announcing its financial results for the second quarter ended June 30, 2026. As previously announced and set forth in the Press Release, the Company will host a conference call to discuss its financial results for the second quarter ended June 30, 2026, provide a corporate update, and conclude with Q&A with the Company’s c…
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operations and Financial Condition. On May 12, 2026, Tenon Medical, Inc., a Delaware corporation (the “Company”), issued a press release (the “Press Release”) announcing its financial results for the first quarter ended March 31, 2026. As previously announced and set forth in the Press Release, the Company will host a conference call to discuss its financial results for the first quarter ended March 31, 2026, provide a corporate update, and conclude with Q&A with the Company’s cove…
Results of Operations and Financial Condition. On March 19, 2026, Tenon Medical, Inc., a Delaware corporation (the “Company”), issued a press release (the “Press Release”) announcing its financial results for the fourth quarter and fiscal year ended December 31, 2025. As previously announced and set forth in the Press Release, the Company will host a conference call to discuss its financial results for the fourth quarter and fiscal year ended December 31, 2025, provide a corporate update, and…
Results of Operations and Financial Condition. On February 5, 2026, Tenon Medical, Inc., a Delaware corporation (the “Company”), issued a press release announcing unaudited revenue for the fourth quarter of 2025 totaling $1.45 to $1.48 million, which represents an approximately 90% increase in revenue year-over-year, as compared to the fourth quarter of 2024 fiscal year, as well as unaudited revenue for the 2025 fiscal year totaling $3.91 to $3.94 million, which represents an approximately 20…
R esults of Operations and Financial Condition. On March 12, 2024, Tenon Medical, Inc. (the “Company”) issued a press release announcing its earnings for the fourth quarter ended December 31, 2023 and the fiscal year ended December 31, 2023. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information set forth under this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of th…